Patent · US Active

Non-recombinant human insulin-like growth factor binding protein concentrate

US12167255B2 · kind B2 · utility

0Cited by

4References

21Claims

0Family size

Assignee

Siemens Healthcare Diagnostics Inc. · US

Inventors

Spencer Lin · Walnut Creek, US
Kwasi Osae-Kwapong · White Plains, US
Omar Quraishi · Maplewood, US
Seema Sinha · Rancho Santa Margarita, US
Michele Smith · Indianapolis, US
SunRay DiFrancesco · Peekskill, US
Ryan Spears · Stamford, US
Dharini Rawal · Springtown, US
Debra Hovanec-Burns · Wappingers Falls, US
Robert A. Owens · Amherst, US

Key dates

Filing date	Nov 16, 2020
Grant date	Dec 10, 2024
Priority date	—
Expiry date	Sep 3, 2042

Classification

Technology area (CPC H)Electricity
CPC primaryH04W84/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A human insulin-like growth factor (IGF) binding protein stock solution and method of making the same include a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium. The concentration of the nr-IGFBP-3 in the stock solution ranges from about 16 micrograms per milliliter (μg/ml) to about 40 μg/ml. A kit includes a set of calibrators for nr-IGFBP-3. The set of calibrators includes the nr-IGFBP-3 in different concentrations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.